The Impact of Low-FODMAPs, Gluten-Free, and Ketogenic Diets on Gut Microbiota Modulation in Pathological Conditions - PubMed (original) (raw)

Review

The Impact of Low-FODMAPs, Gluten-Free, and Ketogenic Diets on Gut Microbiota Modulation in Pathological Conditions

Sofia Reddel et al. Nutrients. 2019.

Abstract

The gut microbiota performs several essential protective, structural, and metabolic functions for host health. The maintenance of a beneficial microbiota requires a homeostatic equilibrium within microbial communities, and between the microorganisms and the host. The gut microbiota composition may be affected by external factors, among them diet habits may be considered most important. In some pathological conditions such as irritable bowel syndrome (IBS), celiac disease (CD), or neurological disorders (ND), specific dietary regimens as low-fermentable, oligo-, di-, mono-saccharides and polyols (FODMAPs), ketogenic (KD), and gluten-free (GFD) diets are considered therapeutic. These kinds of diets are characterized by a reduction or exclusion of a specific nutrient from the entire dietary pattern. Despite these alimentary regimens showing beneficial effects on disease symptoms, they can affect microbiota composition, especially if they are protracted for a long time. To date, only a few studies have reported the effects of these diets on gut microbiota. In this review, we discuss the effects of low-FODMAPs, KD, and GFD on gut microbiota modulation in pathological conditions, advancing the possibility of depicting a balanced diet and developing personalized dietary intervention protocols.

Keywords: dietary patterns; gluten-free diet; ketogenic diet; low-FODMAPs diet; microbiota.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Kamada N., Seo S.-U., Chen G.Y., Núñez G. Role of the gut microbiota in immunity and inflammatory disease. Nat. Rev. Immunol. 2013;13:321–335. doi: 10.1038/nri3430. - DOI - PubMed
    1. Clarke G., Stilling R.M., Kennedy P.J., Stanton C., Cryan J.F., Dinan T.G. Minireview: Gut microbiota: The neglected endocrine organ. Mol. Endocrinol. 2014;28:1221–1238. doi: 10.1210/me.2014-1108. - DOI - PMC - PubMed
    1. Freestone P.P.E., Sandrini S.M., Haigh R.D., Lyte M. Microbial endocrinology: How stress influences susceptibility to infection. Trends Microbiol. 2008;16:55–64. doi: 10.1016/j.tim.2007.11.005. - DOI - PubMed
    1. Evans J.M., Morris L.S., Marchesi J.R. The gut microbiome: The role of a virtual organ in the endocrinology of the host. J. Endocrinol. 2013;218:R37–R47. doi: 10.1530/JOE-13-0131. - DOI - PubMed
    1. Ursell L.K., Knight R. Xenobiotics and the human gut microbiome: Metatranscriptomics reveal the active players. Cell Metab. 2013;17:317–318. doi: 10.1016/j.cmet.2013.02.013. - DOI - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources